EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Comparison of Intratracheal Salbutamol Plus Surfactant Versus Surfactant Alone in Preterm Neonates with Respiratory Distress Syndrome: A Randomized Controlled Trial

European Journal of Clinical Pharmacy · 25.06.2026 · 8 (1) · 1104-1108

DOI: 10.61336/im/26-06-166 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 25.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare the effect of intratracheal administration of salbutamol along with surfactant therapy as against surfactant alone on preterm babies with Respiratory Distress Syndrome (RDS).

Methods

A randomized controlled trial was conducted in the Neonatal Intensive Care Unit (NICU), Department of Pediatrics, Children Hospital, Pakistan Institute of Medical Sciences (PIMS), Islamabad for a period of six months. Eighty-two preterm infants of either gender, having a gestational age between 28 weeks and less than 37 weeks and fulfilling the clinical as well as radiological criteria of RDS were recruited in the study. They were randomly divided into two equal groups. Group A was administered intratracheal surfactant alone while Group B was administered intratracheal surfactant along with salbutamol. The main criterion was INSURE failure (need for reintubation within 72 hours).

Results

The demographics and the clinical status of both groups were similar at baseline. The incidence of INSURE failure was significantly low in Group B compared to Group A (29.3% vs. 51.2%, P=0.043). Complication rate was significantly low in neonates who received a combination of surfactant and salbutamol (22.0% vs. 43.9%, P=0.034). Mechanical ventilation was needed in fewer patients from Group B (22.0% vs. 39.0%, P=0.093). There was a significant reduction in hospital stay for Group B (80.8±44.8 hours vs. 94.7±77.7 hours, P=0.003). Mortality was significantly low in the same group (22.0% vs. 43.9%, P=0.034).

Conclusion

The administration of intratracheal salbutamol as an adjuvant to surfactant therapy led to a significant decrease in INSURE failure, complication rates, hospital stay and mortality in premature neon. Keywords: Respiratory Distress Syndrome; Salbutamol; Surfactant; Mechanical Ventilation; Preterm Neonates.

Zitieren

APA

(2026). Comparison of Intratracheal Salbutamol Plus Surfactant Versus Surfactant Alone in Preterm Neonates with Respiratory Distress Syndrome: A Randomized Controlled Trial. European Journal of Clinical Pharmacy, 8(1), 1104-1108. https://doi.org/10.61336/im/26-06-166

Vancouver

Comparison of Intratracheal Salbutamol Plus Surfactant Versus Surfactant Alone in Preterm Neonates with Respiratory Distress Syndrome: A Randomized Controlled Trial. European Journal of Clinical Pharmacy. 2026;8(1):1104-1108. doi:10.61336/im/26-06-166

BibTeX
@article{euvimed2026,
  title = {Comparison of Intratracheal Salbutamol Plus Surfactant Versus Surfactant Alone in Preterm Neonates with Respiratory Distress Syndrome: A Randomized Controlled Trial},
  journal = {European Journal of Clinical Pharmacy},
  year = {2026},
  volume = {8},
  number = {1},
  pages = {1104--1108},
  doi = {10.61336/im/26-06-166}
}
Kostenlos starten →